+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Organ and Bionics Market Size, Share & Trends Analysis Report by Product (Artificial Heart, Liver, Kidney Pancreas, Exoskeleton, Cochlear Implant), by Technology (Mechanical, Electronic), by Region, and Segment Forecasts, 2020 - 2027

  • ID: 3292635
  • Report
  • July 2020
  • Region: Global
  • 110 pages
  • Grand View Research

FEATURED COMPANIES

  • ABIOMED, INC
  • Berlin Heart GmbH
  • Biomet, Inc
  • Cochlear, LTD
  • Ekso Bionics
  • Iwalk, Inc
  • MORE
Artificial Organ and Bionics Market Growth & Trends

The global artificial organ and bionics market size is expected to reach USD 53.9 billion by the year 2027, expanding at a CAGR of 9.6%. Growing incidence of organ failure has resulted in massive growth in the human made organ and bionics devices. Rising demand for donors to transplant kidney, heart, lungs, liver, and pancreas is a major factor boosting market growth. Moreover, many biotechnology and medical device companies have begun to concentrate on the development of 3D printed bionic. These devices use myoelectric technology and sensory electric technology that enables mobility of synthetic human body parts.

Increasing number of product launches and speedy FDA approval of these devices are bridging the shortage of donors. Rising R&D in the field of synthetic human body parts is also boosting artificial organs and bionics market growth. For instance, February 2020, the U.S. FDA approved Carmat’s early feasibility study of its artificial heart. The device is an alternative for heart transplant for people suffering from end stage biventricular heart failure. Thus, with increasing healthcare expenditure and speedy FDA approval of synthetic human body parts, the market is expected to see robust growth during the forecast period.

Artificial Organ And Bionics Market Report Highlights
  • Artificial organs segment was the largest revenue-generating amongst others due to escalating number of transplant procedures
  • The bionics segment is also expected to witness the highest CAGR owing to advancement in products
  • The kidney segment accounted for the largest market share of approximately 57.0% in the year 2019
  • The cochlear implant segment is expected to register highest growth rate owing to increasing geriatric population
  • North America was the leading regional segment in 2019 and is expected to maintain its position during the forecast period owing to presence of advance healthcare facilities
  • Existence of large number of research laboratories, biotechnology, and medical device companies in North America is the major factor contributing to its large share.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ABIOMED, INC
  • Berlin Heart GmbH
  • Biomet, Inc
  • Cochlear, LTD
  • Ekso Bionics
  • Iwalk, Inc
  • MORE
Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Region scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Analyst's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Artificial Organ and Bionics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of organ failure
3.4.1.2. Technological advancement in transplantation method
3.4.1.3. Developed tissue banks
3.4.1.4. Increasing aging population
3.4.2. Market restraint analysis
3.4.2.1. Shortage of organ donors
3.4.2.2. Ethical and cultural issues
3.5. Artificial Organ Transplant and Bionics Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies

Chapter 4. Artificial Organ and Bionics Market by Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Artificial organs
4.1.1.1. Kidney
4.1.1.2. Heart
4.1.1.3. Liver
4.1.1.4. Lungs
4.1.1.5. Pancreas
4.1.2. Artificial Bionics
4.1.2.1. Cochlear implants
4.1.2.2. Exoskeleton
4.1.2.3. Bionic limbs
4.1.2.4. Vision bionics
4.1.2.5. Brain bionics
4.2. Product Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Artificial Organ and Bionic Market by Product Outlook
4.4.1. Artificial Bionics
4.4.1.1. Kidney
4.4.1.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.1.2. Heart
4.4.1.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.1.3. Liver
4.4.1.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.1.4. Lungs
4.4.1.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.1.5. Pancreas
4.4.1.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.2. Artificial Bionics
4.4.2.1. Cochlear Implants
4.4.2.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.2.2. Exoskeleton
4.4.2.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.2.3. Bionic limbs
4.4.2.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.2.4. Vision bionics
4.4.2.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.4.2.5. Brain bionics
4.4.2.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 5. Artificial Organ and Transplant Market: Technology Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Mechanical
5.1.2. Electronic
5.2. Technology Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Artificial Organ and Bionic Market by Technology Outlook
5.4.1. Mechanical
5.4.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
5.4.2. Electronic
5.4.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 6. Artificial Organ and Bionics Market: Country Estimates & Trend Analysis
6.1. Country Market Share Analysis, 2019 & 2027
6.2. County Market Dashboard
6.3. Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2019
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.7.2. U.S.
6.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.7.3. Canada
6.7.3.1. Canada market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.8.2. U.K.
6.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.8.3. Germany
6.8.3.1. Germany market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.8.4. France
6.8.4.1. France market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.8.5. Italy
6.8.5.1. Italy market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.8.6. Spain
6.8.6.1. Spain market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.9.2. Japan
6.9.2.1. Japan market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.9.3. China
6.9.3.1. China market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.9.4. India
6.9.4.1. India market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.9.5. South Korea
6.9.5.1. South Korea market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.9.6. Australia
6.9.6.1. Australia market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.10.2. Brazil
6.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.10.3. Mexico
6.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.10.4. Argentina
6.10.4.1. Argentina market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.10.5. Colombia
6.10.5.1. Colombia market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.11. Middle East & Africa
6.11.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.11.2. South Africa
6.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.11.3. Saudi Arabia
6.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.11.4. UAE
6.11.4.1. UAE market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2019
7.3.4. ABIOMED, INC
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Procedure benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Berlin Heart GmbH
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Procedure benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Biomet, Inc
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Procedure benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Zimmer Biomet
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Procedure benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Boston Scientific Corporation
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Procedure benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Cochlear, LTD
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Procedure benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Edward Lifesciences Corporations
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Procedure benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Ekso Bionics
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Procedure benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Heartware International, Inc
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Procedure benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Iwalk, Inc
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Procedure benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Jarvik Heart, Inc.
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Procedure benchmarking
7.3.14.4. Strategic initiatives
7.3.15. SynCardia Systems, Inc
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Procedure benchmarking
7.3.15.4. Strategic initiatives
Note: Product cover images may vary from those shown
  • ABIOMED, INC
  • Berlin Heart GmbH
  • Biomet, Inc
  • Zimmer Biomet
  • Boston Scientific Corporation
  • Cochlear, LTD
  • Edward Lifesciences Corporations
  • Ekso Bionics
  • Heartware International, Inc
  • Iwalk, Inc
  • Jarvik Heart, Inc.
  • SynCardia Systems, Inc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll